MyFinsight
Home
Blog
About
Contact
allo: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$8,525K
Short-term investments
$214,379K
Cash and cash
equivalents
$37,815K
Other long-term
assets
$3,513K
Restricted cash
$10,292K
Deposit placed in escrow
$23,472K
Property and equipment,
net
$75,896K
Operating lease
right-of-use asset
$40,935K
Long-term investments
$24,944K
Total current assets
$260,719K
Total assets
$439,771K
Total liabilities and
stockholders equity
$439,771K
Total stockholders
equity
$315,329K
Total liabilities
$124,442K
Accumulated deficit
-$1,971,899K
Accumulated other
comprehensive loss
$235K
Additional paid-in capital
$2,286,770K
Other long-term
liabilities
$15,475K
Lease liability,
noncurrent
$77,134K
Total current
liabilities
$31,833K
Common stock, 0.001 par
value 400,000,000...
$223K
Accrued and other
current liabilities
$28,134K
Accounts payable
$3,699K
Back
Back
Balance Sheet
source: myfinsight.com
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)